Dihydroergotamine Mesylate en es it fr

Dihydroergotamine Mesylate Brand names, Dihydroergotamine Mesylate Analogs

Dihydroergotamine Mesylate Brand Names Mixture

  • No information avaliable

Dihydroergotamine Mesylate Chemical_Formula

C33H37N5O5

Dihydroergotamine Mesylate RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Dihydroergotamine Mesylate fda sheet

Dihydroergotamine_Mesylate FDA

Dihydroergotamine Mesylate msds (material safety sheet)

Dihydroergotamine_Mesylate MSDS

Dihydroergotamine Mesylate Synthesis Reference

No information avaliable

Dihydroergotamine Mesylate Molecular Weight

583.678 g/mol

Dihydroergotamine Mesylate Melting Point

No information avaliable

Dihydroergotamine Mesylate H2O Solubility

No information avaliable

Dihydroergotamine Mesylate State

Solid

Dihydroergotamine Mesylate LogP

No information avaliable

Dihydroergotamine Mesylate Dosage Forms

Liquid

Dihydroergotamine Mesylate Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Dihydroergotamine Mesylate Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Dihydroergotamine Mesylate Absorption

Interpatient variable and may be dependent on the administration technique

Dihydroergotamine Mesylate side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Dihydroergotamine Mesylate Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Dihydroergotamine Mesylate Organisms Affected

Humans and other mammals